Our coverage includes global equity markets, focusing on earnings trends, institutional flows, and sector-level performance analysis.
As of 2026-04-08, Keros Therapeutics Inc. (KROS) is trading at a current price of $12.5, marking a 2.12% gain on the day. This analysis examines key technical levels, recent market context, and potential future scenarios for the biotech stock, with no recent earnings data available for the company as of this publication. KROS has seen relatively range-bound trading in recent weeks, with price action largely tied to broader biotech sector flows rather than company-specific news. Key takeaways for
Is Keros Therapeutics (KROS) Stock heavily shorted | Price at $12.50, Up 2.12% - Collar Trade
KROS - Stock Analysis
4887 Comments
932 Likes
1
Shanerica
Regular Reader
2 hours ago
{协议答案}
👍 141
Reply
2
Tymberlynn
Active Contributor
5 hours ago
{协议答案}
👍 131
Reply
3
Newland
Influential Reader
1 day ago
{协议答案}
👍 196
Reply
4
Hudayfi
Legendary User
1 day ago
{协议答案}
👍 167
Reply
5
Caidon
Regular Reader
2 days ago
{协议答案}
👍 55
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.